Global Precision Cancer Therapies Market Research Report 2023

Report ID: 1992319 | Published Date: Jan 2025 | No. of Page: 80 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Precision Cancer Therapies Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Hormone Therapy
        1.2.3 Immunotherapies
        1.2.4 Targeted Therapy
        1.2.5 Monoclonal Antibody Therapy
        1.2.6 Gene Therapy
    1.3 Market by Application
        1.3.1 Global Precision Cancer Therapies Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Diagnostic Centers
        1.3.4 Oncology Clinics
        1.3.5 Research Institutes
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Precision Cancer Therapies Market Perspective (2017-2028)
    2.2 Precision Cancer Therapies Growth Trends by Region
        2.2.1 Precision Cancer Therapies Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Precision Cancer Therapies Historic Market Size by Region (2017-2022)
        2.2.3 Precision Cancer Therapies Forecasted Market Size by Region (2023-2028)
    2.3 Precision Cancer Therapies Market Dynamics
        2.3.1 Precision Cancer Therapies Industry Trends
        2.3.2 Precision Cancer Therapies Market Drivers
        2.3.3 Precision Cancer Therapies Market Challenges
        2.3.4 Precision Cancer Therapies Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Precision Cancer Therapies Players by Revenue
        3.1.1 Global Top Precision Cancer Therapies Players by Revenue (2017-2022)
        3.1.2 Global Precision Cancer Therapies Revenue Market Share by Players (2017-2022)
    3.2 Global Precision Cancer Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Precision Cancer Therapies Revenue
    3.4 Global Precision Cancer Therapies Market Concentration Ratio
        3.4.1 Global Precision Cancer Therapies Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Therapies Revenue in 2021
    3.5 Precision Cancer Therapies Key Players Head office and Area Served
    3.6 Key Players Precision Cancer Therapies Product Solution and Service
    3.7 Date of Enter into Precision Cancer Therapies Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Cancer Therapies Breakdown Data by Type
    4.1 Global Precision Cancer Therapies Historic Market Size by Type (2017-2022)
    4.2 Global Precision Cancer Therapies Forecasted Market Size by Type (2023-2028)
5 Precision Cancer Therapies Breakdown Data by Application
    5.1 Global Precision Cancer Therapies Historic Market Size by Application (2017-2022)
    5.2 Global Precision Cancer Therapies Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Precision Cancer Therapies Market Size (2017-2028)
    6.2 North America Precision Cancer Therapies Market Size by Country (2017-2022)
    6.3 North America Precision Cancer Therapies Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Precision Cancer Therapies Market Size (2017-2028)
    7.2 Europe Precision Cancer Therapies Market Size by Country (2017-2022)
    7.3 Europe Precision Cancer Therapies Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Precision Cancer Therapies Market Size (2017-2028)
    8.2 Asia-Pacific Precision Cancer Therapies Market Size by Country (2017-2022)
    8.3 Asia-Pacific Precision Cancer Therapies Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Precision Cancer Therapies Market Size (2017-2028)
    9.2 Latin America Precision Cancer Therapies Market Size by Country (2017-2022)
    9.3 Latin America Precision Cancer Therapies Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Precision Cancer Therapies Market Size (2017-2028)
    10.2 Middle East & Africa Precision Cancer Therapies Market Size by Country (2017-2022)
    10.3 Middle East & Africa Precision Cancer Therapies Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Detail
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Precision Cancer Therapies Introduction
        11.1.4 Abbott Laboratories Revenue in Precision Cancer Therapies Business (2017-2022)
        11.1.5 Abbott Laboratories Recent Development
    11.2 Bayer HealthCare
        11.2.1 Bayer HealthCare Company Detail
        11.2.2 Bayer HealthCare Business Overview
        11.2.3 Bayer HealthCare Precision Cancer Therapies Introduction
        11.2.4 Bayer HealthCare Revenue in Precision Cancer Therapies Business (2017-2022)
        11.2.5 Bayer HealthCare Recent Development
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Detail
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Precision Cancer Therapies Introduction
        11.3.4 GlaxoSmithKline Revenue in Precision Cancer Therapies Business (2017-2022)
        11.3.5 GlaxoSmithKline Recent Development
    11.4 OncoGenex Pharmaceuticals
        11.4.1 OncoGenex Pharmaceuticals Company Detail
        11.4.2 OncoGenex Pharmaceuticals Business Overview
        11.4.3 OncoGenex Pharmaceuticals Precision Cancer Therapies Introduction
        11.4.4 OncoGenex Pharmaceuticals Revenue in Precision Cancer Therapies Business (2017-2022)
        11.4.5 OncoGenex Pharmaceuticals Recent Development
    11.5 Hospira
        11.5.1 Hospira Company Detail
        11.5.2 Hospira Business Overview
        11.5.3 Hospira Precision Cancer Therapies Introduction
        11.5.4 Hospira Revenue in Precision Cancer Therapies Business (2017-2022)
        11.5.5 Hospira Recent Development
    11.6 Boehringer Ingelheim
        11.6.1 Boehringer Ingelheim Company Detail
        11.6.2 Boehringer Ingelheim Business Overview
        11.6.3 Boehringer Ingelheim Precision Cancer Therapies Introduction
        11.6.4 Boehringer Ingelheim Revenue in Precision Cancer Therapies Business (2017-2022)
        11.6.5 Boehringer Ingelheim Recent Development
    11.7 AstraZeneca
        11.7.1 AstraZeneca Company Detail
        11.7.2 AstraZeneca Business Overview
        11.7.3 AstraZeneca Precision Cancer Therapies Introduction
        11.7.4 AstraZeneca Revenue in Precision Cancer Therapies Business (2017-2022)
        11.7.5 AstraZeneca Recent Development
    11.8 Aveo Pharmaceuticals
        11.8.1 Aveo Pharmaceuticals Company Detail
        11.8.2 Aveo Pharmaceuticals Business Overview
        11.8.3 Aveo Pharmaceuticals Precision Cancer Therapies Introduction
        11.8.4 Aveo Pharmaceuticals Revenue in Precision Cancer Therapies Business (2017-2022)
        11.8.5 Aveo Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Precision Cancer Therapies Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Hormone Therapy
    Table 3. Key Players of Immunotherapies
    Table 4. Key Players of Targeted Therapy
    Table 5. Key Players of Monoclonal Antibody Therapy
    Table 6. Key Players of Gene Therapy
    Table 7. Global Precision Cancer Therapies Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Precision Cancer Therapies Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Precision Cancer Therapies Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Precision Cancer Therapies Market Share by Region (2017-2022)
    Table 11. Global Precision Cancer Therapies Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Precision Cancer Therapies Market Share by Region (2023-2028)
    Table 13. Precision Cancer Therapies Market Trends
    Table 14. Precision Cancer Therapies Market Drivers
    Table 15. Precision Cancer Therapies Market Challenges
    Table 16. Precision Cancer Therapies Market Restraints
    Table 17. Global Precision Cancer Therapies Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Precision Cancer Therapies Market Share by Players (2017-2022)
    Table 19. Global Top Precision Cancer Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Therapies as of 2021)
    Table 20. Ranking of Global Top Precision Cancer Therapies Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Precision Cancer Therapies Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Precision Cancer Therapies Product Solution and Service
    Table 24. Date of Enter into Precision Cancer Therapies Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Precision Cancer Therapies Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Precision Cancer Therapies Revenue Market Share by Type (2017-2022)
    Table 28. Global Precision Cancer Therapies Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Precision Cancer Therapies Revenue Market Share by Type (2023-2028)
    Table 30. Global Precision Cancer Therapies Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Precision Cancer Therapies Revenue Market Share by Application (2017-2022)
    Table 32. Global Precision Cancer Therapies Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Precision Cancer Therapies Revenue Market Share by Application (2023-2028)
    Table 34. North America Precision Cancer Therapies Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Precision Cancer Therapies Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Precision Cancer Therapies Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Precision Cancer Therapies Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Precision Cancer Therapies Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Precision Cancer Therapies Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Precision Cancer Therapies Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Precision Cancer Therapies Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Precision Cancer Therapies Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Precision Cancer Therapies Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Abbott Laboratories Company Detail
    Table 45. Abbott Laboratories Business Overview
    Table 46. Abbott Laboratories Precision Cancer Therapies Product
    Table 47. Abbott Laboratories Revenue in Precision Cancer Therapies Business (2017-2022) & (US$ Million)
    Table 48. Abbott Laboratories Recent Development
    Table 49. Bayer HealthCare Company Detail
    Table 50. Bayer HealthCare Business Overview
    Table 51. Bayer HealthCare Precision Cancer Therapies Product
    Table 52. Bayer HealthCare Revenue in Precision Cancer Therapies Business (2017-2022) & (US$ Million)
    Table 53. Bayer HealthCare Recent Development
    Table 54. GlaxoSmithKline Company Detail
    Table 55. GlaxoSmithKline Business Overview
    Table 56. GlaxoSmithKline Precision Cancer Therapies Product
    Table 57. GlaxoSmithKline Revenue in Precision Cancer Therapies Business (2017-2022) & (US$ Million)
    Table 58. GlaxoSmithKline Recent Development
    Table 59. OncoGenex Pharmaceuticals Company Detail
    Table 60. OncoGenex Pharmaceuticals Business Overview
    Table 61. OncoGenex Pharmaceuticals Precision Cancer Therapies Product
    Table 62. OncoGenex Pharmaceuticals Revenue in Precision Cancer Therapies Business (2017-2022) & (US$ Million)
    Table 63. OncoGenex Pharmaceuticals Recent Development
    Table 64. Hospira Company Detail
    Table 65. Hospira Business Overview
    Table 66. Hospira Precision Cancer Therapies Product
    Table 67. Hospira Revenue in Precision Cancer Therapies Business (2017-2022) & (US$ Million)
    Table 68. Hospira Recent Development
    Table 69. Boehringer Ingelheim Company Detail
    Table 70. Boehringer Ingelheim Business Overview
    Table 71. Boehringer Ingelheim Precision Cancer Therapies Product
    Table 72. Boehringer Ingelheim Revenue in Precision Cancer Therapies Business (2017-2022) & (US$ Million)
    Table 73. Boehringer Ingelheim Recent Development
    Table 74. AstraZeneca Company Detail
    Table 75. AstraZeneca Business Overview
    Table 76. AstraZeneca Precision Cancer Therapies Product
    Table 77. AstraZeneca Revenue in Precision Cancer Therapies Business (2017-2022) & (US$ Million)
    Table 78. AstraZeneca Recent Development
    Table 79. Aveo Pharmaceuticals Company Detail
    Table 80. Aveo Pharmaceuticals Business Overview
    Table 81. Aveo Pharmaceuticals Precision Cancer Therapies Product
    Table 82. Aveo Pharmaceuticals Revenue in Precision Cancer Therapies Business (2017-2022) & (US$ Million)
    Table 83. Aveo Pharmaceuticals Recent Development
    Table 84. Research Programs/Design for This Report
    Table 85. Key Data Information from Secondary Sources
    Table 86. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Precision Cancer Therapies Market Share by Type: 2021 VS 2028
    Figure 2. Hormone Therapy Features
    Figure 3. Immunotherapies Features
    Figure 4. Targeted Therapy Features
    Figure 5. Monoclonal Antibody Therapy Features
    Figure 6. Gene Therapy Features
    Figure 7. Global Precision Cancer Therapies Market Share by Application in 2021 & 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Diagnostic Centers Case Studies
    Figure 10. Oncology Clinics Case Studies
    Figure 11. Research Institutes Case Studies
    Figure 12. Precision Cancer Therapies Report Years Considered
    Figure 13. Global Precision Cancer Therapies Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Precision Cancer Therapies Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Precision Cancer Therapies Market Share by Region: 2021 VS 2028
    Figure 16. Global Precision Cancer Therapies Market Share by Players in 2021
    Figure 17. Global Top Precision Cancer Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Therapies as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Precision Cancer Therapies Revenue in 2021
    Figure 19. North America Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Precision Cancer Therapies Market Share by Country (2017-2028)
    Figure 21. United States Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Precision Cancer Therapies Market Share by Country (2017-2028)
    Figure 25. Germany Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Precision Cancer Therapies Market Share by Region (2017-2028)
    Figure 33. China Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Precision Cancer Therapies Market Share by Country (2017-2028)
    Figure 41. Mexico Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Precision Cancer Therapies Market Share by Country (2017-2028)
    Figure 45. Turkey Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Precision Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Abbott Laboratories Revenue Growth Rate in Precision Cancer Therapies Business (2017-2022)
    Figure 48. Bayer HealthCare Revenue Growth Rate in Precision Cancer Therapies Business (2017-2022)
    Figure 49. GlaxoSmithKline Revenue Growth Rate in Precision Cancer Therapies Business (2017-2022)
    Figure 50. OncoGenex Pharmaceuticals Revenue Growth Rate in Precision Cancer Therapies Business (2017-2022)
    Figure 51. Hospira Revenue Growth Rate in Precision Cancer Therapies Business (2017-2022)
    Figure 52. Boehringer Ingelheim Revenue Growth Rate in Precision Cancer Therapies Business (2017-2022)
    Figure 53. AstraZeneca Revenue Growth Rate in Precision Cancer Therapies Business (2017-2022)
    Figure 54. Aveo Pharmaceuticals Revenue Growth Rate in Precision Cancer Therapies Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Bayer HealthCare
GlaxoSmithKline
OncoGenex Pharmaceuticals
Hospira
Boehringer Ingelheim
AstraZeneca
Aveo Pharmaceuticals
Frequently Asked Questions
Precision Cancer Therapies report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Precision Cancer Therapies report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Precision Cancer Therapies report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Predictive Learning

Predictive Learning market is segmented by players, region (country), by Type and by Application. ... Read More

Pregelatinized Flour

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More